Showing results (71-80 of 131) with videos related to
Sort By:
Pageof 14
Biochemical Pharmacology|June 1, 2020
Characterization of water-soluble esters of nitrobenzoxadiazole-based GSTP1-1 inhibitors for cancer treatmentVeronica Di Paolo, Chiara Fulci, Dante Rotili, et al.Journal of Mammary Gland Biology and Neoplasia|May 11, 2018
Radiological, Histological and Chemical Analysis of Breast Microcalcifications: Diagnostic Value and Biological SignificanceRita Bonfiglio, Manuel Scimeca, Nicola Toschi, et al.Oncogene|October 28, 2018
Forcing ATGL expression in hepatocarcinoma cells imposes glycolytic rewiring through PPAR-α/p300-mediated acetylation of p53Luca Di Leo, Rolando Vegliante, Fabio Ciccarone, et al.International Journal of Molecular Sciences|January 6, 2021
The Paradox Effect of Calcification in Carotid Atherosclerosis: Microcalcification is Correlated with Plaque InstabilityManuela Montanaro, Manuel Scimeca, Lucia Anemona, et al.Nuclear Medicine and Biology|February 17, 2019
Prostate cancer and inflammation: A new molecular imaging challenge in the era of personalized medicineOrazio Schillaci, Manuel Scimeca, Donata Trivigno, et al.International Journal of Molecular Sciences|May 14, 2025
Mercury Bioaccumulation in Female Breast Cancer Is Associated to CXCR4 ExpressionFrancesca Servadei, Rita Bonfiglio, Renata Sisto, et al.Journal of Clinical Medicine|June 12, 2026
Molecular Evaluation of RNA-Based Immune Checkpoint Profiling in Clear Cell Renal Cell CarcinomaErica Giacobbi, Valeria Palumbo, Francesca Servadei, et al.Pharmacological Research|June 3, 2020
Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanomaPedro Miguel Lacal, Maria Grazia Atzori, Federica Ruffini, et al.Discover Oncology|March 21, 2024
Genetically driven predisposition leads to an unusually genomic unstable renal cell carcinomaManuel Scimeca, Valentina Rovella, Sabrina Caporali, et al.Cancers|July 29, 2023
Programmed Cell Death Pathways in Cholangiocarcinoma: Opportunities for Targeted TherapyManuel Scimeca, Valentina Rovella, Valeria Palumbo, et al.Pageof 14